Karaya/Gellan-Gum-Based Bilayer Films Containing 3,3′-Diindolylmethane-Loaded Nanocapsules: A Promising Alternative to Melanoma Topical Treatment
Authors:
- Jéssica Brandão ReolonJéssica Brandão Reolon
- Camila Parcianello SaccolCSCamila Parcianello Saccol
- Bárbara Felin OsmariBOBárbara Felin Osmari
- Daiane Britto de OliveiraDODaiane Britto de Oliveira
- Vinicius Costa PradoVPVinicius Costa Prado
- Fernanda Licker CabralFCFernanda Licker Cabral
- Lucas Saldanha da RosaLRLucas Saldanha da Rosa
- Giancarlo Cervo RechiaGRGiancarlo Cervo Rechia
- Daniela Bitencourt Rosa LealDLDaniela Bitencourt Rosa Leal
- Letícia CruzLetícia Cruz
Open Access
- 29 August 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (9) , 2234
Abstract
This study aimed to incorporate nanocapsules containing 3,3′-diindolylmethane (DIM) with antitumor activity into a bilayer film of karaya and gellan gums for use in topical melanoma therapy. Nanocarriers and films were prepared by interfacial deposition of the preformed polymer and solvent casting methods, respectively. Incorporating DIM into nanocapsules increased its antitumor potential against human melanoma cells (A-375) (IC50 > 24.00 µg/mL free DIM × 2.89 µg/mL nanocapsules). The films were transparent, hydrophilic (θ < 90°), had homogeneous thickness and weight, and had a DIM content of 106 µg/cm2. Radical ABTS+ scavenger assay showed that the DIM films presented promising antioxidant action. Remarkably, the films showed selective bioadhesive potential on the karaya gum side. Considering the mechanical analyses, the nanotechnology-based films presented appropriate behavior for cutaneous application and controlled DIM release profile, which could increase the residence time on the application site. Furthermore, the nanofilms were found to increase the permeation of DIM into the epidermis, where melanoma develops. Lastly, the films were non-hemolytic (hemolysis test) and non-irritant (HET-CAM assay). In summary, the combination of karaya and gellan gum in bilayer films that contain nanoencapsulated DIM has demonstrated potential in the topical treatment of melanoma and could serve as a viable option for administering DIM for cutaneous melanoma therapy.Keywords
Funding Information
- Fundação para Amparo da Pesquisa no Rio Grande do Sul (FAPERGS) (17/2551-0001041-8)
This publication has 92 references indexed in Scilit:
- Encapsulation of indole-3-carbinol and 3,3′-diindolylmethane in zein/carboxymethyl chitosan nanoparticles with controlled release property and improved stabilityFood Chemistry, 2013
- Antioxidant Function of Isoflavone and 3,3′-Diindolylmethane: Are They Important for Cancer Prevention and Therapy?Antioxidants & Redox Signaling, 2013
- Nanocarriers and nanoparticles for skin care and dermatological treatmentsIndian Dermatology Online Journal, 2013
- Pharmacokinetic evaluation and In Vitro–In Vivo Correlation (IVIVC) of novel methylene-substituted 3,3′ diindolylmethane (DIM)European Journal of Pharmaceutical Sciences, 2012
- Nanoemulsões como sistemas de liberação parenteral de fármacosQuímica Nova, 2012
- Higuchi equation: Derivation, applications, use and misuseInternational Journal of Pharmaceutics, 2011
- Soft Nanotechnology with Soft NanoparticlesAngewandte Chemie International Edition, 2005
- Characterization of cellulosic hot-melt extruded films containing lidocaineEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Nanocapsule formation by interfacial polymer deposition following solvent displacementInternational Journal of Pharmaceutics, 1989
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983